EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari(University of Bergamo), Peter Reichardt(Helios Hospital Berlin-Buch), Anna Paioli(Istituto Ortopedico Rizzoli), Nina Louise Jebsen(Haukeland University Hospital), Thekla von Kalle(Olgahospital), Wolfgang E. Berdel(University Hospital Münster), Stefan Bielack(Olgahospital), Marilena Cesari(Istituto Ortopedico Rizzoli), Virginia Ferraresi(Cancer Institute (WIA)), Alessandro Comandone(Ospedale Humanitas Gradenigo), Bodil Bjerkehagen(Oslo University Hospital), Mikael Eriksson(Herlev Hospital), Fatime Krasniqi(University Hospital of Basel), Rossella Bertulli(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandra Longhi(Istituto Ortopedico Rizzoli), Mathias Werner(Helios Klinikum Emil von Behring), Giovanni Grignani(Candiolo Cancer Institute), Benjamin Sorg(Olgahospital), Stefanie Hecker‐Nolting(University College London Hospitals NHS Foundation Trust), Marco Gambarotti(Istituto Ortopedico Rizzoli), Emanuela Palmerini(Istituto Ortopedico Rizzoli), Sigbjørn Smeland(Oslo University Hospital), Piero Picci(Istituto Ortopedico Rizzoli), Gerlinde Egerer(Heidelberg University), Davide María Donati(University of Modena and Reggio Emilia), Kirsten Sundby Hall(Oslo University Hospital), Otte Brosjö(Karolinska University Hospital), Anne-Katrin Kasparek(Medical University of Graz), Per-Ulf Tunn(Helios Hospital Berlin-Buch), Rudolf Schwarz(Universität Hamburg), Sylvie Lorenzen(Technical University of Munich), Matthias Kevric(Universität Hamburg), Odd R. Monge(Haukeland University Hospital)
Cited by 124
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
|New England Journal of Medicine|2016|1.3k